Moleculin Biotech today announced that, pursuant to its continued collaboration with MD Anderson it has developed and licensed what it believes is a major breakthrough in its effort to develop a new cancer treatment.
Moleculin Biotech today announced that, pursuant to its continued collaboration with MD Anderson it has developed and licensed what it believes is a major breakthrough in its effort to develop a new cancer treatment.